NCT01625494 - Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy | Biotech Hunter

Enrollment

158

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Hypertension

Interventions

DRUG

Irbesartan/Amlodipine (150/5mg)

Pharmaceutical form: tablet Route of administration: oral

DRUG

Irbesartan/Amlodipine (150/10mg)

Pharmaceutical form: tablet Route of administration: oral

DRUG

Irbesartan/Amlodipine (300/5mg)

Pharmaceutical form: tablet Route of administration: oral

DRUG

Irbesartan/Amlodipine (300/10mg)

Pharmaceutical form:tablet Route of administration: oral

Trial Locations (1)

Sanofi-Aventis Administrative Office, Moscow